Skip to content

APLS

Apellis Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$41.03
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+90.2%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 14, 2026Francois Cedric · director, officer: Chief Executive OfficerA-Award143,750$0.00
May 14, 2026DeLong Mark Jeffrey · officer: Chief Business & Strat OfficerA-Award41,250$0.00
May 14, 2026Boucher Kelley · officer: Chief People OfficerA-Award30,146$0.00
May 14, 2026Nicholson Nur · officer: Chief Technical OfficerA-Award22,610$0.00
May 14, 2026Sullivan Timothy Eugene · officer: Chief Financial OfficerA-Award29,070$0.00
May 14, 2026MELTZER LESLIE · officer: Chief Research and DevelopmentA-Award22,610$0.00
May 14, 2026DeLong Mark Jeffrey · officer: Chief Business & Strat OfficerA-Award36,606$0.00
May 14, 2026Sullivan Timothy Eugene · officer: Chief Financial OfficerA-Award30,620$0.00
May 14, 2026Sullivan Timothy Eugene · officer: Chief Financial OfficerA-Award58,140$0.00
May 14, 2026Boucher Kelley · officer: Chief People OfficerA-Award15,073$0.00
May 14, 2026Sullivan Timothy Eugene · officer: Chief Financial OfficerA-Award41,250$0.00
May 14, 2026Watson David O. · officer: General CounselA-Award28,508$0.00
May 14, 2026Chopas James George · officer: VP/Chief Accounting OfficerA-Award16,150$0.00
May 14, 2026Watson David O. · officer: General CounselA-Award41,250$0.00
May 14, 2026Chopas James George · officer: VP/Chief Accounting OfficerA-Award5,625$0.00
May 14, 2026DeLong Mark Jeffrey · officer: Chief Business & Strat OfficerA-Award18,303$0.00
May 14, 2026Nicholson Nur · officer: Chief Technical OfficerA-Award24,284$0.00
May 14, 2026Nicholson Nur · officer: Chief Technical OfficerA-Award45,220$0.00
May 14, 2026MELTZER LESLIE · officer: Chief Research and DevelopmentA-Award45,220$0.00
May 14, 2026Deschatelets Pascal · officer: Chief Scientific OfficerA-Award41,250$0.00
May 14, 2026Francois Cedric · director, officer: Chief Executive OfficerA-Award97,976$0.00
May 14, 2026Deschatelets Pascal · officer: Chief Scientific OfficerA-Award10,030$0.00
May 14, 2026Deschatelets Pascal · officer: Chief Scientific OfficerA-Award25,840$0.00
May 14, 2026Nicholson Nur · officer: Chief Technical OfficerA-Award41,250$0.00
May 14, 2026Deschatelets Pascal · officer: Chief Scientific OfficerA-Award12,920$0.00
May 14, 2026Watson David O. · officer: General CounselA-Award55,986$0.00
May 14, 2026Chopas James George · officer: VP/Chief Accounting OfficerA-Award8,075$0.00
May 14, 2026Francois Cedric · director, officer: Chief Executive OfficerA-Award87,108$0.00
May 14, 2026Baumal Caroline · officer: Chief Medical OfficerA-Award26,396$0.00
May 14, 2026Watson David O. · officer: General CounselA-Award27,993$0.00
Institutional positioning

13F filings over the trailing two quarters

New 124Increased 92Reduced 80Sold out 326
FilerActionSharesFiled
BLACKROCK, INC.Increased13,536,964May 13, 2026
AVORO CAPITAL ADVISORS LLCUnchanged12,222,222Mar 16, 2026
AVORO CAPITAL ADVISORS LLCReduced12,222,222May 15, 2026
MORGAN STANLEYReduced10,042,399May 15, 2026
STATE STREET CORPIncreased6,844,990May 15, 2026
UBS GROUP AGIncreased6,206,681May 5, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position5,404,559May 8, 2026
PENTWATER CAPITAL MANAGEMENT LPNew Position5,250,000May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4,768,944May 15, 2026
DEEP TRACK CAPITAL, LPReduced4,532,374May 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Increased4,183,918May 15, 2026
RTW INVESTMENTS, LPReduced3,685,045May 15, 2026
HBK INVESTMENTS L PNew Position3,550,000May 15, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCReduced3,518,471May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,265,402May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 14, 2026